We are live on ! Find out more
EWS

Eagle Wealth Strategies Portfolio holdings

AUM $262M
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+7.99%
1 Year Est. Return
+31.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$179M
AUM Growth
+$15.8M
Cap. Flow
+$4.96M
Cap. Flow %
2.78%
Top 10 Hldgs %
69.98%
Holding
109
New
12
Increased
39
Reduced
33
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 7.79%
2 Financials 6.69%
3 Healthcare 3.71%
4 Consumer Discretionary 3.57%
5 Energy 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAB icon
101
Gabelli Equity Trust
GAB
$1.78B
$108K 0.06%
18,624
GUT
102
Gabelli Utility Trust
GUT
$575M
$105K 0.06%
18,138
AKBA icon
103
Akebia Therapeutics
AKBA
$351M
$36.4K 0.02%
10,000
CRNT icon
104
Ceragon Networks
CRNT
$209M
$24.6K 0.01%
10,000
INVZ icon
105
Innoviz Technologies
INVZ
$91.4M
$17.7K 0.01%
+10,797
New +$9.43K
BMY icon
106
Bristol-Myers Squibb
BMY
$135B
-3,912
Closed -$239K
LEN icon
107
Lennar Class A
LEN
$21B
-1,850
Closed -$212K
PRU icon
108
Prudential Financial
PRU
$42.9B
-1,818
Closed -$203K
TEVA icon
109
Teva Pharmaceuticals
TEVA
$40.1B
-24,918
Closed -$383K

Similar funds

Eagle Wealth Strategies's Q2 2025 Portfolio in Review

As of Q2 2025, Eagle Wealth Strategies held 109 positions worth $179M, up 9.7% from $163M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Eagle Wealth Strategies's Q2 2025 filing shows 12 new, 39 increased, 33 reduced and 4 closed positions. Its largest new stake was iShares National Muni Bond ETF: 32,528 shares worth $3.4M. The largest sale was Teva Pharmaceuticals, an estimated $383K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Eagle Wealth Strategies's largest Q2 2025 buy was iShares National Muni Bond ETF: 32,528 shares worth $3.4M.
  • Eagle Wealth Strategies added most to Vanguard Morningstar Mid-Cap ETF in Q2 2025, an estimated $425K increase.
  • Eagle Wealth Strategies's biggest Q2 2025 reduction was JPMorgan Chase, cutting an estimated $288K.
  • Eagle Wealth Strategies fully exited Teva Pharmaceuticals in Q2 2025, selling an estimated $383K.
  • Eagle Wealth Strategies's ten largest holdings make up 70% of its $179M portfolio in Q2 2025.
  • Eagle Wealth Strategies opened 12 new positions and closed 4 in Q2 2025.
  • Eagle Wealth Strategies's portfolio value rose 9.7% quarter-over-quarter to $179M.

Based on Eagle Wealth Strategies's 13F filing for Q2 2025, filed 17 Jul 2025.